Loading...
XNYS
ZBH
Market cap17bUSD
Jul 09, Last price  
89.23USD
1D
1.91%
1Q
-4.18%
Jan 2017
-10.94%
IPO
227.07%
Name

Zimmer Biomet Holdings Inc

Chart & Performance

D1W1MN
XNYS:ZBH chart
P/E
24.48
P/S
2.10
EPS
3.65
Div Yield, %
1.08%
Shrs. gr., 5y
-0.82%
Rev. gr., 5y
6.08%
Revenues
8.23b
+7.20%
3,495,400,0003,897,500,0004,121,100,0004,095,400,0004,220,200,0004,451,800,0004,471,700,0004,623,400,0004,673,300,0005,997,800,0007,668,400,0007,803,300,0007,932,900,0007,982,200,0006,127,500,0006,827,300,0006,939,900,0007,394,200,0007,678,600,0008,231,500,000
Net income
705m
-21.97%
834,500,000773,200,000848,600,000717,400,000596,900,000760,800,000755,000,000761,000,000720,300,000147,000,000305,900,0001,813,800,000-379,200,0001,131,600,000-138,900,000401,600,000231,400,0001,024,000,000903,800,000705,200,000
CFO
1.70b
+13.18%
1,040,700,0001,084,400,0001,038,100,0001,117,500,0001,193,500,0001,176,900,0001,151,900,000963,100,0001,060,500,000849,800,0001,632,200,0001,582,300,0001,747,400,0001,585,800,0001,204,500,0001,499,200,0001,284,700,0001,581,600,0001,499,400,0001,697,000,000
Dividend
Dec 30, 20250.24 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zimmer Biomet Holdings, Inc., along with its various subsidiaries, is a prominent player in the global musculoskeletal healthcare industry, providing its specialized solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. The company's comprehensive offerings span the design, manufacture, and commercialization of a wide array of innovative devices and products. These include orthopedic reconstructive solutions for knees and hips; S.E.T. offerings such as sports medicine, biologics, foot and ankle care, extremity treatments, and trauma interventions; spinal products encompassing diverse medical devices and surgical instruments; and specialized items for facial and cranial reconstruction. It also develops products designed to stabilize and fixate chest bones, critical for healing or reconstruction following open-heart surgery, trauma, or for correcting deformities. Additionally, Zimmer Biomet provides advanced dental products, comprising reconstructive implants, prosthetics, and regenerative materials, alongside essential robotic technologies, surgical tools, and bone cements. These extensive product lines and solutions are specifically engineered to address and treat patients afflicted by disorders or injuries impacting their bones, joints, and surrounding soft tissues. The company caters to a diverse clientele of healthcare professionals and institutions, including orthopedic, neuro, and oral surgeons, dentists, hospitals, as well as various distribution partners such as stocking distributors, healthcare dealers, agents, and large healthcare purchasing organizations. Established in 1927 and headquartered in Warsaw, Indiana, the entity previously known as Zimmer Holdings, Inc. underwent a rebranding in June 2015, adopting its current name, Zimmer Biomet Holdings, Inc.
IPO date
Jul 25, 2001
Employees
18,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT